PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases

NCT06380881 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Bone Metastases

Interventions

DRUG: SHR-2017

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.